Digestion
Original Paper: Helicobacter pylori
Healing of Lymphocytic Gastritis by Eradication of Helicobacter pyloriMüller H. · Volkholz H. · Stolte M.Institute of Pathology, Klinikum Bayreuth, Germany
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Published online: January 15, 2001
Issue release date: 2001
Number of Print Pages: 6
Number of Figures: 3
Number of Tables: 2
ISSN: 0012-2823 (Print)
eISSN: 1421-9867 (Online)
For additional information: https://www.karger.com/DIG
Abstract
Background: It is not yet clear whether lymphocytic gastritis might not be a sequela of Helicobacter pylori (Hp) infection. The aim of the present pilot study was, therefore, to investigate whether lymphocytic gastritis can be cured by Hp eradication, which, if affirmed, would provide indirect evidence for an etiopathogenic relationship. Patients and Methods: 98 of 220 patients with lymphocytic gastritis diagnosed between 1988 and 1998 were investigated at least twice, with 61 of them undergoing Hp eradication treatment. In 29 of these patients, the pretreatment histological work-up using the Warthin-Starry silver stain revealed Hp colonisation, while in the remaining 32 patients the biopsies from the antrum and corpus were negative for Hp. The other 37 patients received no treatment, and served as a control group. Results: Both in the group with Hp-positive, and in the group with Hp-negative histology prior to treatment, eradication treatment led to healing of the gastritis, i.e. to regression of the gastritis parameters including normalisation of the intra-epithelial lymphocyte count, in 93.1% and 84.3% of the cases, respectively. In the control group the histological findings did not change. Conclusions: The results of our retrospective study support the notion that most cases of lymphocytic gastritis might be a consequence of Hp infection. This, however, needs to be clarified definitively by a prospective, randomized, double-blind study.
© 2001 S. Karger AG, Basel
Related Articles:
References
-
Haot J, Delos M, Wallez L, Hardy N, Lenzen B, Jouret-Mourin A: Les lymphocytes intraépithéliaux en pathologic gastrique inflammatoire. Acta Endosc 1986;16:61–67.
-
Haot J, Jouret-Mourin A, Delos M: Etude anatome-clinique d’une série de gastrites chroniques caractérisées par une infiltration lymphocytaire intra-épitheliale. Acta Endosc 1986;16:69–74.
-
Moutier F, Martin J: Deux cas de gastrite varioliforme. Arch Mal App Digestif 1947;36:155–161.
- Dixon MF, Genta RM, Yardley JH, Correa P: Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161–1181.
-
Kushima R, Borchard F: Lymphocytic gastritis: Autoimmune disease or variant of Helicobacter gastritis? Verh Dtsch Ges Path 1996;80:208–211.
- Lynch DA, Sobala GM, Dixon MF, Gledhill A, Jackson P, Crabtree JE, Axon AT: Lymphocytic gastritis and associated small bowel disease: A diffuse lymphocytic gastroenteropathy? J Clin Pathol 1995;48:939–945.
- Oberhuber G, Bodingbauer M, Mosberger I, Stolte M, Vogelsang H: High proportion of Granzyme B-positive (activated) intraepithelial and lamina propria lymphocytes in lymphocytic gastritis. Am J Surg Pathol 1998;22:450–458.
- Haot J, Journet A, Willette M, Gossuin A, Mainguet P: Lymphocytic gastritis: Prospective study of its relationship with varioliform gastritis. Gut 1990;31:282–285.
- Haot J, Berger F, Andre C, Moulinier B, Mainguet P, Lambert R: Lymphocytic gastritis versus varioliform gastritis. A historical series revisited. J Pathol 1989;158:19–22.
- Haot J, Hamichi L, Wallez L, Mainguet P: Lymphocytic gastritis: a newly described entity, a retrospective endoscopic and histological study. Gut 1988;29:1258–1264.
-
Haot J, Wallez L, Jouret-Mourin A, Hardy N: La gastrite à lymphocytes. Une nouvelle entité? Acta Endoscopia 1985;15:187–188.
- Dixon MF, Wyatt JI, Burke DA, Rathbone BJ: Lymphocytic gastritis – relationship to Campylobacter pylori infection. J Pathol 1988;154:125–132.
- Lambert R, André C, Moulinier B, Bugnon B: Diffuse varilioform gastritis. Digestion 1978;17:159–167.
-
Herz VR, Lombardi E, Wipping F, Stolte M: Helicobacter pylori associated giant fold gastritis with gastric protein-loss syndrome mimicking Ménétrier’s disease. Fortschr Med 1992;110:37–40.
External Resources
- Stolte M, Bätz Ch, Bayerdörffer E, Eidt S: Helicobacter pylori eradication in the treatment and differential diagnosis of giant folds in the corpus and fundus of the stomach. Z Gastroenterol 1995;33:198–201.
- Wolber R, Owen D, Del Buono L, Appelman H, Freeman H: Lymphocytic gastritis in patients with celiac sprue or spruelike intestinal disease. Gastroenterology 1990;98:310–315.
- Wolfsen HC, Carpenter HA, Talley NJ: Menetrier’s disease. A form of hypertrophic gastropathy or gastritis. Gastroenterology 1993;104:1310–1319.
- Jaskiewicz K, Price SK, Zak J, Louwrens HD: Lymphocytic gastritis in nonulcer dyspepsia. Dig Dis Sci 1991;36:1079–1083.
- Alsaigh N, Odze R, Goldman H, Antonioli D, Ott MJ, Leichtner A: Gastric and esophageal intraepithelial lymphocytes in pediatric celiac disease. Am J Surg Pathol 1996;20:865–870.
- De Giacomo C, Gianatti A, Negrini R, Perotti P, Bawa P, Maggiore G, Fiocca R: Lymphocytic gastritis: A positive relationship with celiac disease. J Pediatr 1994;124:57–62.
- Vogelsang H, Oberhuber G, Wyatt J: Lymphocytic gastritis and gastric permeability in patients with celiac disease. Gastroenterology 1996;111:73–77.
- Wolber RA, Owen DA, Anderson FH: Lymphocytic gastritis and giant folds associated with gastrointestinal protein loss. Mod Pathol 1991;4:13–15.
-
Rutgeerts L, Stuer A, Vandenborre K, Ghillebert G, Tanghe W: Lymphocytic gastritis: Clinical and endoscopic presentation and long-term follow-up. Acta Gastro-Enterol Belg 1995;58:238–242.
- Niemelä S, Karttunen T, Kerola T, Karttunen R: Ten year follow up study of lymphocytic gastritis: Further evidence on Helicobacter pylori as a cause of lymphocytic gastritis and corpus gastritis. J Clin Pathol 1995;48:1111–1116.
- Sirigu F, Dessi A, Usai P, Capeccioni S, Masia AM: A retrospective study on the incidence of lymphocytic gastritis in patients with Helicobacter pylori infection. Riv Eur Sci Med Farmacol 1995;17:85–89.
- Murata I, Yoshikawa I, Kuroda T, Tarabu A, Miura T, Otsuki M: Varioliform gastritis and duodenitis associated with protein-losing gastroenteropathy, treated with omeprazole. J Gastroenterol 1996;31:109–113.
- Stolte M, Bethke B: Elimination of Helicobacter pylori under treatment with omeprazole. Z Gastroenterol 1990;28:271–274.
- Logan RPH, Walker MM, Misiewicz JJ, Gummet PA, Karim QN, Baron JH: Changes in the distribution of Helicobacter pylori during treatment with omeprazole. Gut 1995;36:12–16 .
- Feeley KM, Heneghan MA, Stevens FM, Mccarthy CF: Lymphocytic gastritis and celiac disease: Evidence of a positive association. J Clin Pathol 1998;51:207–210.
- Weiss AA, Yoshida EM, Poulin M, Gascoyne RD, Owen DA: Massive bleeding from multiple gastric ulcerations in a patient with lymphocytic gastritis and celiac sprue. J Clin Gastroenterol 1997;25:354–357.
-
Lerner A, Ephros M, Shavshin N, Hornstein I, Rennert H: Helicobacter pylori infection and active celiac disease are associated. Gastroenterology 1993;104:A132.
-
Stolte M, Bätz Ch, Eidt S: Giant fold gastritis- A special form of Helicobacter pylori associated gastritis. Z Gastroenterol 1993;31:281–293.
-
Allgaier H-P, Schwacha H, Köhler G, Ochs A, Budde M, Blum HE: Helicobacter pylori-induced hypertrophic gastritis: An important differential-diagnosis of giant folds in the stomach. Endoskopie heute 1996;265–269.
- Hayat M, Arora DS, Dixon MF, Clark B, O’Mahony S: Effects of Helicobacter pylori eradication on the natural history of lymphocytic gastritis. Gut 1999;45:495–498.
Article / Publication Details
Published online: January 15, 2001
Issue release date: 2001
Number of Print Pages: 6
Number of Figures: 3
Number of Tables: 2
ISSN: 0012-2823 (Print)
eISSN: 1421-9867 (Online)
For additional information: https://www.karger.com/DIG
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
